Anti-Cdk8 antibody [EPR21005]
- RabMAb
- Recombinant
- KO Validated
- What is this?
4
(1 Review)
|
(5 Publications)
Rabbit Recombinant Monoclonal CDK8 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 5 publications.
View Alternative Names
Cyclin-dependent kinase 8, Cell division protein kinase 8, Mediator complex subunit CDK8, Mediator of RNA polymerase II transcription subunit CDK8, Protein kinase K35, CDK8
- IP
Unknown
Immunoprecipitation - Anti-Cdk8 antibody [EPR21005] (AB229192)
Cdk8 was immunoprecipitated from 0.35 mg of SW480 (human colorectal adenocarcinoma cell line) whole cell lysate with ab229192 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab229192 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1/10,000 dilution.
Lane 1 : SW480 whole cell lysate 10 μg (Input).
Lane 2 : ab229192 IP in SW480 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab229192 in SW480 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Immunoprecipitation - Anti-Cdk8 antibody [EPR21005] (ab229192)
Predicted band size: 53 kDa
Observed band size: 53 kDa
false
- WB
Lab
Western blot - Anti-Cdk8 antibody [EPR21005] (AB229192)
Lanes 1-4 : Merged signal (red and green). Green - ab229192 observed at 53 kDa. Red - loading control ab8245 observed at 37 kDa.
ab229192 Anti-Cdk8 antibody [EPR21005] was shown to specifically react with Cdk8 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265087 (knockout cell lysate ab257885) was used. Wild-type and Cdk8 knockout samples were subjected to SDS-PAGE. ab229192 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Cdk8 antibody [EPR21005] (ab229192) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
CDK8 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human CDK8 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-cdk8-knockout-hela-cell-line-ab265087'>ab265087</a>)
Lane 3:
HAP1 cell lysate at 20 µg
Lane 4:
Daudi cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution
Predicted band size: 53 kDa
Observed band size: 53 kDa
false
- WB
Supplier Data
Western blot - Anti-Cdk8 antibody [EPR21005] (AB229192)
Blocking and dilution buffer : 5% NFDM/TBST.
ab229192 was shown to specifically react with Cdk8 in wild-type HAP1 cells as signal was lost in Cdk8 knockout cells.
Wild-type and Cdk8 knockout samples were subjected to SDS-PAGE. ab229192 and ab181602 (Rabbit anti-GAPDH loading control) were incubated 1 hour at room temperature at 1/1000 dilution and 1/200,000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/100,000 dilution for 1 hour at room temperature before imaging. The blot was developed on a BIO-RAD® ChemiDoc™ MP instrument using the ECL technique.
All lanes:
Western blot - Anti-Cdk8 antibody [EPR21005] (ab229192) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
Cdk8 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HCT 116 (human colorectal carcinoma cell line) whole cell lysate at 10 µg
Lane 4:
SW480 (Human colorectal adenocarcinoma cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 53 kDa
Observed band size: 53 kDa
false
Exposure time: 48s
- WB
Supplier Data
Western blot - Anti-Cdk8 antibody [EPR21005] (AB229192)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Cdk8 antibody [EPR21005] (ab229192) at 1/1000 dilution
Lane 1:
Human testis lysate at 10 µg
Lane 2:
K562 (human chronic myelogenous leukemia cell line from bone marrow ) whole cell lysate at 10 µg
Secondary
Lane 1:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Lane 2:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 53 kDa
Observed band size: 53 kDa
false
Exposure time: 58s
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cdk8 plays a critical role in modulating transcriptional responses. It does this by becoming part of the Mediator complex which is essential for transcription regulation by RNA Polymerase II. The Mediator complex where Cdk8 acts as a kinase influences the initiation and regulation of gene expression. Cdk8 phosphorylates several transcription factors and other components affecting their ability to activate or repress transcription.
Pathways
Cyclin-dependent kinase 8 functions prominently in the Wnt/β-catenin signaling and Notch signaling pathways both essential for development and cell differentiation. In the Wnt pathway it interacts closely with proteins like β-catenin to influence gene activation. In the Notch pathway it modulates transcription factors related to cellular differentiation processes. These interactions underline its role as a regulator in carefully managing cellular responses to signaling cues.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
The FEBS journal 291:5214-5235 PubMed39434428
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 26:389 PubMed37456160
2023
Applications
Unspecified application
Species
Unspecified reactive species
Chemical biology & drug design 102:101-114 PubMed36892495
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature structural & molecular biology 29:1000-1010 PubMed36220895
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 46:1175-1185 PubMed32705162
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com